SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-13-038396
Filing Date
2013-07-30
Accepted
2013-07-30 18:31:21
Documents
2
Period of Report
2013-07-26

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c575332_3x1.html 3  
1 MAIN DOCUMENT DESCRIPTION c575332_3x1.xml 3 3538
2 POWER OF ATTORNEY c575332_24.htm EX-24 3625
  Complete submission text file 0001209191-13-038396.txt   8757
Mailing Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O ARCA BIOPHARMA, INC. 8001 ARISTA PLACE, STE 430 BROOMFIELD CO 80021
Business Address
Woosley Raymond L. (Reporting) CIK: 0001582095 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 13997069